Kristen M Oelschlager sold $665K of Castle Biosciences (CSTL)

Executed Nov 11 2025, disclosed Nov 13 2025, 2 days later.

Value, as filed

$665K

18,932 sh × $35.10

Executed

Nov 11 2025

the trade date, as filed

Disclosed

Nov 13 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kristen M Oelschlager Chief Operating Officer profile →

Kristen M Oelschlager (Chief Operating Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $838K of CSTL (24,602 sh across 3 lots, as filed), executed Aug 24.

The name

CSTL

Castle Biosciences, Inc. CSTL · Healthcare · 59 filings in 24 months ticker →

Healthcare · Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kristen M Oelschlager in CSTL

CSTLSALE Castle Biosciences, Inc. $100K
2,807 sh × $35.75
Exec Oct 1
Filed Oct 5 · 4:07 PM ET CSTLSALE Castle Biosciences, Inc. $838K
24,602 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:16 PM ET CSTLSALE Castle Biosciences, Inc. $135K
4,486 sh × $30.00
Exec Aug 3
Filed Aug 5 · 4:18 PM ET CSTLSALE Castle Biosciences, Inc. $200K
8,186 sh × $24.40
Exec Jul 1
Filed Jul 6 · 4:24 PM ET CSTLSALE Castle Biosciences, Inc. $178K
8,587 sh × $20.71
Exec Jun 16
Filed Jun 18 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $585K
14,888 sh × $39.31
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $317K
12,678 sh × $25.04
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $391K
18,007 sh × $21.69
Exec Aug 27 2025
Filed Nov 4 2025 · 5:30 PM ET †